Mentioned in 31 AI use cases across 4 industries
This is like giving pharma companies a super-fast, tireless analyst that can help design, run, and monitor drug trials more efficiently by spotting patterns in patient data and documents that humans would miss or take months to find.
This is like having a super-analyst who can read millions of patient records, insurance claims, and registries to quickly tell you how a drug works in the real world instead of just in clinical trials.
Like having a tireless medical researcher who reads millions of scientific papers and instantly pulls out the evidence you need for a specific drug, disease, or trial question.
This is like giving your drug development teams a super-fast assistant that can read all past trial data, spot patterns humans miss, and help design and run smarter clinical trials.
Think of clinical trials as a long, expensive treasure hunt to find out if a new drug really works. This paper describes how AI can act like a super-smart assistant at every step—finding the right patients faster, spotting hidden safety signals earlier, and predicting which trials are most likely to succeed—so you spend less time and money to reach the answer.
Like giving your clinical operations team a super-organised project manager who can instantly find the right patients, keep all sites on the same page, and flag issues before timelines slip.
Like having a super-analyst who reviews years of cancer trial data and operational experience to suggest trial designs that are realistic for sites and patients before you launch them.
Like giving your clinical strategy team a tireless super-analyst that has read every past trial, guideline, and paper, then helps design the smartest, leanest plan for your next drug.
Like having a super-fast, tireless research nurse who can read thousands of charts in minutes and flag exactly which cancer patients qualify for which clinical trials.
Think of AI in clinical trials as a super‑organized project manager and data analyst that reads mountains of medical data, spots patterns faster than humans, and flags problems early so studies finish faster and safer.
Like having a smart assistant that reads every clinical trial entry on ClinicalTrials.gov and turns the messy, technical listings into clean, searchable summaries and insights for sponsors and sites.
Like having a tireless medical librarian who scans thousands of scientific papers and automatically pulls out the key facts about how drugs work and what side effects they cause.
This is like having a super-powered medical researcher that can read millions of patient records, studies, and reports, then summarize what actually happens to patients in the real world when they use a drug.
This is like having a super‑paralegal and research analyst that instantly reads all FDA guidance on decentralized clinical trials and explains what it means for your study designs and evidence packages.
Like having a smart inspection manager that constantly reviews all trial data and documents, then tells your team where the real risks are so they inspect the right sites and patients first.
This is like having a super-calculator that helps design clinical trials which can change course mid-way—such as adjusting dosage or sample size—without breaking FDA rules or statistical rigor.
Like giving pharma teams a tireless digital research assistant that continually scans scientific evidence and summarizes what matters for your drugs and disease areas.
Like a smart dating app for clinical research, this AI reads people’s health records and trial requirements to quickly find the best matches between volunteers and studies.
This is like giving oncologists a super-assistant that can read many different kinds of medical information at once—genomic profiles, imaging, lab results, and clinical notes—and then suggest patterns, risks, and treatment options that would be hard for any one human to spot alone.
Like having a tireless scientist who reads all the clinical and real‑world evidence for a drug and summarizes what’s relevant for your decision in plain language.
Instead of using AI only as a mad scientist to invent new pills, pharma is using it as a super-optimizer that quietly trims waste and speeds up all the boring-but-expensive parts of the business.
Think of AI in clinical trials as an ultra-fast, tireless research assistant that helps pharma teams find the right patients, design better studies, monitor participants in real time, and clean up data much faster than humans alone—so new drugs get to patients sooner.
This is like giving drug development teams a super-smart assistant that can read piles of medical data, predict which patients and trial designs will work best, and continuously monitor results so trials finish faster and with fewer costly mistakes.
This is like giving the FDA and drug makers a smarter microscope and calculator that can sift through mountains of trial data, medical records, and scientific evidence to see more clearly whether a new drug is safe and works as intended.
Think of BC Catalyst as a super-smart librarian for hospitals and research labs: it safely connects and reads genetic, clinical, and other health data stored in many different places, then uses AI to help scientists and pharma companies quickly find the right patients and design better-targeted treatments.